Evidence map›Paper›PMID 39095659›Full record

ArticleCommunications biology2024

Differentially localized protein identification for breast cancer based on deep learning in immunohistochemical images.

Zihan Zhang, Lei Fu, Bei Yun, Xu Wang, Xiaoxi Wang, Yifan Wu, Junjie Lv, Lina Chen, Wan Li

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zihan ZhangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150000, China.
Lei FuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150000, China.
Bei YunCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150000, China.
Xu WangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150000, China.
Xiaoxi WangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150000, China.
Yifan WuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150000, China.
Junjie LvCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150000, China.
Lina ChenCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150000, China. chenlina@ems.hrbmu.edu.cn.ORCID 0000-0002-4576-6814
Wan LiCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150000, China. liwan@hrbmu.edu.cn.ORCID 0000-0002-9797-0315

Funding

National Natural Science Foundation of China (National Science Foundation of China) 61702141Natural Science Foundation of Heilongjiang Province LH2021F043
6 · The paper itself

Abstract

The mislocalization of proteins leads to breast cancer, one of the world's most prevalent cancers, which can be identified from immunohistochemical images. Here, based on the deep learning framework, location prediction models were constructed using the features of breast immunohistochemical images. Ultimately, six differentially localized proteins that with stable differentially predictive localization, maximum localization differences, and whose predicted results are not affected by removing a single image are obtained (CCNT1, NSUN5, PRPF4, RECQL4, UTP6, ZNF500). Further verification reveals that these proteins are not differentially expressed, but are closely associated with breast cancer and have great classification performance. Potential mechanism analysis shows that their co-expressed or co-located proteins and RNAs may affect their localization, leading to changes in interactions and functions that further causes breast cancer. They have the potential to help shed light on the molecular mechanisms of breast cancer and provide assistance for its early diagnosis and treatment.

Indexed as

Breast NeoplasmsDeep LearningImmunohistochemistryBiomarkers, TumorFemaleHumansBiomarkers, Tumor

Identifiers

PMID39095659
PMCPMC11297317

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.